Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial (Q34530459)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial |
scientific article |
Statements
1 reference
Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial (English)
1 reference
Michael E Weinblatt
1 reference
Edward C Keystone
1 reference
Daniel E Furst
1 reference
Larry W Moreland
1 reference
Michael H Weisman
1 reference
Charles A Birbara
1 reference
Leah A Teoh
1 reference
Steven A Fischkoff
1 reference
Elliot K Chartash
1 reference
1 January 2003
1 reference
1 reference
48
1 reference
1
1 reference
35-45
1 reference
Identifiers
1 reference
1 reference